K161265 is an FDA 510(k) clearance for the NuVasive® VersaTie System. Classified as Bone Fixation Cerclage, Sublaminar (product code OWI), Class II - Special Controls.
Submitted by Nu Vasive, Incorporated (San Diego, US). The FDA issued a Cleared decision on July 15, 2016 after a review of 71 days - a notably fast clearance cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3010 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Nu Vasive, Incorporated devices